According to WuXi Biologics's latest financial reports and stock price the company's current Operating Margin is 35.08%. At the end of 2022 the company had an Operating Margin of 35.09%.
Year | Operating Margin | Change |
---|---|---|
2022 | 35.09% | -9.58% |
2021 | 38.81% | 10.79% |
2020 | 35.03% | 23.85% |
2019 | 28.28% | -2.84% |
2018 | 29.11% | 55.16% |
2017 | 18.76% | 5.51% |
2016 | 17.78% | 51.43% |
2015 | 11.74% | -20.5% |
2014 | 14.77% |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.